I agree that this site is using cookies. You can find further informations here.
X
Rossor, A.M.
~ 900  results:
Search for persons X
?
1

EFNS task force on molecular diagnosis of neurologic disord..:

Members of the task force on molecular diagnosis of neurologic disorders: T. Gasser, Germany; M. Dichgans, Germany; J. Finsterer, Austria; I. Hausmanowa‐Petrusewicz, Poland; K. Jurkat‐Rott, Germany; T. Klopstock, Germany; E. Leguern, France; A.‐E. Lehesjoki, Finland; F. Lehmann‐Horn, Germany; T. Lynch, UK; H. Morris, UK; M. Rossor, UK; O.K. Steinlein, Germany; N. Wood, UK; J. Zaremba, Poland; M. Zeviani, Italy; A. Zoharn, Israel
European Journal of Neurology.  8 (2001)  5 - p. 407-424 , 2001
Link: https://doi.org/10.1046/..
 
?
2

Routine blood monitoring in maintenance immunoglobulin trea..:

Keh, R. ; Kahlil, A. ; Nihoyannopoulos, L....
Journal of the Neurological Sciences.  408 (2020)  - p. 116527 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Are we prepared for clinical trials in Charcot-Marie-Tooth ..:

Rossor, A.M. ; Shy, M.E. ; Reilly, M.M.
Brain Research.  1729 (2020)  - p. 146625 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Corrigendum to Routine blood monitoring in maintenance Immu..:

Keh, R. ; Khalil, A. ; Nihoyannopoulos, L....
Journal of the Neurological Sciences.  417 (2020)  - p. 116988 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Gene replacement therapy after neuropathy onset provides th..:

Kagiava, A ; Richter, J ; Tryfonos, C...
Human Molecular Genetics.  28 (2019)  21 - p. 3528-3542 , 2019
Link: https://doi.org/10.1093/..
 
?
6

Plasma neurofilament light chain levels are raised in patie..:

Rossor, A.M. ; Sandelius, A. ; Adiutori, R....
Neuromuscular Disorders.  28 (2018)  - p. S23 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Frequency of genetic variants in Charcot-Marie-Tooth diseas..:

Pipis, M. ; Rossor, A.M. ; Polke, J...
Neuromuscular Disorders.  28 (2018)  - p. S22 , 2018
Link: https://doi.org/10.1016/..
 
?
8

A Homozygous Reticulon 2 mutation is a cause of DHMN with p..:

Rossor, A.M. ; Rebelo, A. ; Horga, A....
Neuromuscular Disorders.  27 (2017)  - p. S24 , 2017
Link: https://doi.org/10.1016/..
 
?
9

Thromboembolic risk in inflammatory neuromuscular disease p..:

Spillane, J. ; Englezou, C. ; Sarri-Gonzales, S....
Neuromuscular Disorders.  27 (2017)  - p. S24 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Modulation of cytoplasmic dynein and tubulin modification a..:

Green, R.L. ; Simoes, F.A. ; Reyes-Aldasoro, C.C....
Neuromuscular Disorders.  27 (2017)  - p. S1 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Clinical features and genetic findings in patients with Cha..:

Cortese, A. ; Laurá, M. ; Polke, J.M....
Neuromuscular Disorders.  27 (2017)  - p. S25 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Functional validation of non-coding variants of GJB1 in pat..:

Cortese, A. ; Manole, A. ; Ashokkumar, B....
Neuromuscular Disorders.  27 (2017)  - p. S25 , 2017
Link: https://doi.org/10.1016/..
 
?
13

Neurology: a Queen Square textbook:

Clarke, Charles ; Howard, Robin ; Rossor, M. - Second edition . , 2016
Link: https://onlinelibrary.wi..
 
?
14

P56 Whole-exome sequencing in patients with sensory and mot..:

Horga, A. ; Cottenie, E. ; Liu, Y-T....
Neuromuscular Disorders.  24 (2014)  - p. S22 , 2014
Link: https://doi.org/10.1016/..
 
?
15

P54 A dominant negative mutation in FBXO38 is a cause of di..:

Rossor, A.M. ; d'Ydewalle, C. ; Wooley, J....
Neuromuscular Disorders.  24 (2014)  - p. S21 , 2014
Link: https://doi.org/10.1016/..
 
1-15